CompletedPhase 3

Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036)

587 participantsStarted 2002-12

Plain-language summary

The purpose of this study is to evaluate the cholesterol lowering effectiveness and safety of two investigational drugs in patients with mixed hyperlipidemia (high cholesterol and high triglycerides).

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * High cholesterol and high triglycerides Exclusion Criteria: * Patient has a condition which, in the opinion of the investigator, might pose a risk to the patient, interfere with participation in the study, or does not meet the additional criteria as required by the study

What they're measuring

Plasma LDL-C vs. fenofibrate for 12 weeks.

Trial details

NCT IDNCT00092560

SponsorOrganon and Co

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2003-12

View on ClinicalTrials.gov More Hypercholesterolemia trials